Azurity Pharmaceuticals

Green Park Pharma

The company develops stable liquid formulations of existing medicines for patients who have difficulty swallowing traditional tablets and capsules.

CutisPharma

This company develops unit-of-use compounding kits and oral liquid medications for pharmacists, hospitals and patients requiring customised pharmaceutical formulations.

Aprecia Pharmaceuticals

The company manufactures 3D-printed, fast-dissolving oral medications for pharmaceutical partners and patients with swallowing difficulties.

nextwave-pharmaceuticals

This company develops and commercialises extended-release liquid and chewable medicines for patients with attention deficit hyperactivity disorder and other central nervous system conditions.

Eton Pharmaceuticals

This company develops and commercialises prescription medicines to treat patients living with rare diseases.

Orasis Pharmaceuticals

This company develops prescription eye drops for adults with age-related blurry near vision.

Mirum Pharmaceuticals

This biopharmaceutical company develops and commercialises therapies for rare liver diseases, primarily treating children and adults with cholestatic and metabolic conditions.

ANI Pharmaceuticals

This company develops and manufactures branded and generic prescription medicines for patients requiring rare disease treatments and general healthcare.